Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell wall components and associated enzymes constitute a diverse group of structural molecules and catalytic proteins essential for the survival and integrity of bacteria and fungi (MicrobeNotes, 2023). The cell wall serves as a rigid outer layer that maintains cell shape and protects against high internal osmotic pressure; its absence or degradation typically leads to microbial lysis (Byjus, 2023). In bacteria, the hallmark component is peptidoglycan (murein), a cross-linked polymer of N-acetylglucosamine and N-acetylmuramic acid. The assembly of this structure is facilitated by a suite of enzymes, most notably the penicillin-binding proteins (PBPs) which catalyze transpeptidation, and the Mur family of enzymes involved in precursor synthesis (Oregon State University, 2023). Fungal cell walls, while different in composition, rely on polymers like beta-glucans and chitin (MicrobeNotes, 2023). Because these structures are unique to microbes and absent in human cells, they are among the most successful targets for antimicrobial therapy (BiologyEase, 2021). Drugs such as beta-lactams, glycopeptides, and echinocandins exploit this difference to achieve selective toxicity, effectively treating a wide range of infectious diseases while minimizing host damage (Study.com, 2023).
Inhibition of cell wall synthesis through multiple pathways: beta-lactams bind to and inhibit penicillin-binding proteins (PBPs), preventing peptidoglycan cross-linking; glycopeptides like vancomycin bind to the D-Ala-D-Ala terminus of precursors to block polymerization; fosfomycin inhibits MurA to prevent early precursor formation; and echinocandins inhibit 1,3-beta-glucan synthase in fungi (StatPearls, 2023; PubChem, 2024).
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell wall components and associated enzymes.